The company is not selling any securities and will not receive any proceeds from the sale of its common stock by the selling stockholders.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ENTO:
- Entero Therapeutics CSO Resigns Amid Cost-Cutting Strategy
- Entero Therapeutics announces exercise of warrants, issuance of new warrants
- Entero Therapeutics Announces Abstract on Celiac Disease Research Accepted for Presentation at the 20th International Celiac Disease Symposium
- Entero Therapeutics Announces Peer-Reviewed Publication Unveiling Novel Algorithm for Measuring Intestinal Damage in Celiac Disease
- Entero Therapeutics’ novel algorithm for celiac disease featured in publication